Serum osteoprotegerin levels and their association with preeclampsia severity: a case-control study

Key Points

• Preeclampsia severity correlates significantly with serum osteoprotegerin levels, indicating a possible role in disease progression.
• A notable difference in serum osteoprotegerin levels was observed between severe and mild preeclampsia, highlighting its potential as a biomarker.
• Evaluation was done using a case-control study design, allowing for a comprehensive assessment of osteoprotegerin's implications.
• Findings indicate that serum osteoprotegerin may serve as an important biomarker, warranting further investigation for clinical applications.